To train postgraduate students to be able to practise clinical Nuclear Medicine successfully, undertake basic research and be involved in the training of undergraduate medicine and radiography students. Clinical Nuclear Medicine is the most important component of the programme and is supplemented by applied Nuclear Physics (KDE 802), Applied Physiology (809 FSG 801), Anatomy (ANA 809), Pathology (PAT 801), Radiobiology, Chemistry and Pharmacology (RCF 800). At least six months rotation in the department of Radiology also forms part of the course.
Critical outcomes
On completion of the learning opportunity the student will be able to:
· Function effectively in a team context.
· Identify and solve problems on the basis of critical and creative thinking.
· Collect information and critically analyse, organise and evaluate it.
· Communicate effectively.
· Use science and technology effectively.
On completion of the course the student will be able to:
· Apply knowledge of physiology, pathophysiology and pathology in the practise of clinical Nuclear Medicine.
· Apply basic, applied anatomy knowledge in the practise of clinical Nuclear Medicine.
· Apply physical, radiation biology, radiation protection, physics and instrumentation principles in the practise of clinical Nuclear Medicine.
· Select optimal radiopharmaceuticals for nuclear medicine studies.
· Select the correct nuclear medicine studies (imaging and non-imaging investigations as well as in vitro procedures) for specific disease processes (Appendix 7 contains an overview of the relevant topics).
· Execute nuclear medicine studies (imaging and non-imaging investigations as well as in vitro procedures) according to internationally acceptable standards (Appendix 7 contains an overview of the relevant topics).
· Interpret and report correctly on nuclear medicine studies (imaging and non-imaging investigations as well as in vitro procedures) (Appendix 7 contains an overview of the relevant topics).
· Be skilled in the treatment of relevant disease conditions with unsealed radioactive sources (Appendix 4 contains an overview of the relevant topics).
· Complete a research project successfully ready for submission to a peer-reviewed journal/submit it as an assignment.
· Be involved in student training (undergraduate medical students and radiography students).
Study resources
Any of the new Nuclear Medicine text books that are currently available in the trade, e.g.
· Textbook of Nuclear Medicine. MA Wilson. Raven Press, Philadelphia, 1998.
· Diagnostic Nuclear Medicine. Fourth edition). MP Sandler. Lippincott Williams & Wilkins Publishers, 2002. .
· Nuclear Medicine in Clinical Diagnosis and Treatment.Third edition. Gambhir &Ell
· Nuclear Medicine. RE Henkin. Mosby, 1996.
· Principles of Nuclear Medicine. Second edition. HN Wagner. WB Saunders,1995.
· Textbook of Radiopharmacy: Theory and Practice. Third edition. CB Sampson. Dunitz Martin Ltd, 1999.
· Seminars in Nuclear Medicine
· Journal of Nuclear Medicine
· European Journal of Nuclear Medicine and Molecular Imaging
· American Journal of Nuclear Cardiology
· Nuclear Medicine Communications
· Medical statistics: A commonsense approach. Third edition. MJ Campbell, D Machin.
Wiley Publishers, 1999.
· Nuclear Oncology in Diagnosis and Therapy. I Khalkhali, JC Maublant, SJ Goldsmith (eds.). Lippincott Williams & Wilkins, 2001. ISBN 0781719909.
· Other Nuclear Medicine-related journals that are not listed above
· Evaluation of seminars, presentations during other academic meetings and academic feedback during report-back sessions.
· Attitude, handling of patients and departmental functioning.
· Two radiopharmacy and three clinical Nuclear Medicine tests. Radiopharmacy tests: One when half of the syllabus has been completed and a second one at the end of the lecture series and tutorials.
Clinical tests: One each in the three last years of study.
· Assignment/publication on research work.
· Examination.
Continuous assessment
Seminars/Academic presentations
Attitude, handling of patients and departmental functioning.
Assignment/publication
Written
Clinical Nuclear Medicine, including radiopharmacy
Two papers, 100 marks each
Oral
A number of cases for initial evaluation (60 minutes) and discussion with examiners for
60 minutes
· Assessment will take place as soon as the student has handed in the assignment.
· If it has already been accepted for publication in a peer-reviewed journal, assessment by the examiners will not be necessary.
· If it has been submitted for publication but not yet been accepted, it will be assessed by the examiners.
· Otherwise the research work can be submitted in the form of an article (preferably) or an assignment.
· At the end of the student’s period of study during an official round of examinations arranged by the University (June or November).
· Examinations may not be written before 42 months of training have passed.
Topics in Clinical Sessions
The following is a suggested list of topics for coverage in the clinical sessions. The body of knowledge in Nuclear Medicine is open ended. This list identifies the current major topics of interest in Nuclear Medicine and should be used only as a guide to the extent of the field and should not be used to limit the selection of materials for teaching or evaluation.
PET/CT
1. Principles of PET/CT imaging
2. PET/CT – Oncology: Imaging in Diagnosis / Staging / Prognosis/Recurrence/Therapy
3. PET/CT - Neuropsychiatry
4. PET/CT - Cardiology
5. PET/CT – Infection/Inflammation
Infection
1. WBC - Basics and Kinetics
2. WBC - Labeling and Scanning Techniques
3. WBC - Scans for Soft Tissue Infections
4. WBC - Scans for Bone Infections
5. Gallium 67 - Mechanisms of Uptake of Gallium
- Scanning in Infection
6. Acquired Immune Deficiency Syndrome
Genitourinary
1. Anatomy, Embryology and Congenital Variations
2. Renal Blood Flow (regulation), Tubular functions and Drug Effects
3. Renal Radiopharmaceuticals (DTPA, DMSA, GH, HIPPURAN, MAG3)
4. Compartmental Analysis and Renal Clearance Techniques (GFR, ERPF)
5. Evaluation of the Hypertensive Patient (include Renin-Angiotensin, other investigations, renography, Captopril renography)
6. Acute and Chronic Renal Failure - Clinical, laboratory and imaging evaluation
7. Radionuclide Assessment of Reflux, Obstruction, Renal Masses, Trauma
8. Inflammatory/Infectious Renal Disease
- Clinical
- Gallium Imaging
- Biopsy
9. Transplant Evaluation
10. Renal Stone Disease and Calcium Absorption Studies
11. Testicular Scanning
12. Voiding cystograms (nuclear and radiologic)
Thyroid/Parathyroid
1. Embryology, Anatomy and Congenital Anomalies of Thyroid/Parathyroid
2. Iodine Metabolism and Hormone Synthesis and Peripheral Action of Thyroid Hormones
3. Thyroid Hormone Assays and TRH Testing, etc.
4. a) Iodine uptake and scanning
b) Tc scanning
5. Thyrotoxicosis - Diagnosis and Treatment
6. Thyroid Nodule
- Radionuclide Evaluation & Clinical Evaluation
- Suppression Testing
- Ultrasound and fine needle aspiration
7. Thyroid Cancer - Ablation, I-131 Imaging and Therapy
- Thyroglobulin
8. Miscellaneous Thyroid Disorders (Hashimotos thyroiditis, peripartum thyrotoxicosis, etc)
9. Parathyroid Disorders and Scanning
Endocrine (Non-Thyroid)
1. Hypothalamic - Pituitary Axis - Anatomy, physiology and clinical disorders
2. Anterior Pituitary Hormones - Measurement and stimulation/suppression testing
3. Adrenal - Anatomy, Embryology, Physiology
4. Adrenal - Biochemistry - Synthesis of Steroid Hormones
- Catecholamines
5. Adrenal - Hormonal Evaluation and Radiologic Investigation
6. MIBG - Radiopharmacy and Imaging Studies
7. Iodocholesterol - Radiopharmacy and Imaging Studies
Hematology
1. Formation of Normal Blood Elements
2. Iron Metabolism and Ferrokinetics
3. RBC (Platelet) Survival and Sequestration Studies
4. Blood Volume, Plasma Volume, RBC Mass Measurement
5. Polycythemia and Other Myeloproliferative Disorders
- clinical, diagnosis, and treatment
6. Cell Labeling - cohort versus random
- RBCs, WBCs, platelets
7. Bone Marrow Scanning
8. Blood Cross Matching
- Basics (Blood Bank)
- In vivo Crossmatch
9. Anemia - Clinical and Laboratory
- Schillings test
- PA versus Malabsorption
- Dual versus Single Isotope
Pediatric
1. Special Considerations in Pediatric Nuclear Medicine (eg. sedation protocols, imaging considerations)
2. Aspiration Studies (milk studies)
3. Meckels and other Pediatric GI including IDA Studies
4. Neuroblastoma - Evaluation - MDP
- MIBG
- Therapy - Chemo
- Radionuclide
5. Pediatric Bone and Joint Disease
Cardiovascular
1. Anatomy, Embryology, Congenital Anomalies
2. Physiology - Electrical and Mechanical
- Myocardial Perfusion and Metabolism
3. Heart Catheterization/Echocardiography
4. PET Studies of Heart
5. Exercise Physiology and Stress ECG
Exercise Protocols
Pharmacological Stress Testing
6. Cardiac Arrest and Arrhythmias
7. Infarct Imaging
8. Gated Wall Motion Studies (including evaluation of cardiac toxicity and exercise studies)
9. Evaluation of Valvular Insufficiency (Exercise Wall Motion)
10. First Pass Studies, Cardiac Output and Shunts
11. Radionuclide Angiography and Use of Microspheres, MAA and xenon for Blood Flow/Perfusion
12. Myocardial Perfusion Studies (T1201, Tc99m MIBI, Tc99m Teboroxime)
13. Cardiac SPECT and Phase analysis
14. Thrombolytic Agents and Angioplasty in Cardiovascular Disease
Miscellaneous
1. Dacryoscintigraphy (including Clinical Evaluation, Anatomy and other investigations)
2. Intraocular Tumors - P32 Evaluation
3. Nuclear Medicine and the Pregnant and Breast-feeding Patient
4. Lymphoscintigraphy
5. Gallium 67 Scanning in Oncology
6. Neutron Activation Analysis
7. Whole Body Counting, Total Body and Exchangeable K+, Ca++
8. Intracavitary Radionuclide Treatments, Hepatic Y90 Microspheres, Antibody Therapy, CSF Cyst Rx
9. Monoclonal Antibodies
10. MRI for Abdominal, Pelvic and Chest Disorders
Central Nervous System
1. Anatomy, Embryology, Blood Flow, Blood Brain Barrier
2. Conventional Brain Imaging - Techniques, cerebrovascular disease, infections, neoplasms and trauma
3. Blood Flow Studies - SPECT - Usefulness in various disease processes (HMPAO and Xe 133)
4. Cerebral Metabolism - PET studies
5. Cerebral Edema and Brain Death
6. Neuroradiology a) CT (including stable Xenon)
b) MRI
c) Doppler carotid studies
7. CSF Flow Studies - NPH, Anatomy, Physiology
8. Hydrocephalus - syndromes, shunts and shunt evaluation
Liver/Hepatobiliary and Spleen
1. Anatomy, Embryology, Physiology of Liver/Spleen
2. Radiopharmacy of Radiocolloid, Hepatobiliary and Splenic Imaging (Heat damaged RBC)
3. Hepatic Evaluation - Clinical and Laboratory Assessment
4.a) Evaluation of Mass Lesions in Liver - Sulphur Colloid - HIDA
b) Gallium and RBC Assessment of Liver Lesions
5. Correlative Investigations of Liver Lesions - CT, U/S, MRI
6. Evaluation of Trauma - Liver/Spleen
- HIDA
- Other Investigations
7. Hepatobiliary Imaging - Acute Abdomen
- Bile Leaks
- Pharmacologic Interventions
- Biliary Dyskinesias, Sphincter of Oddi Dysfunction
8. Radionuclide Evaluation of Splenic Disease
Gastrointestinal System
1. Salivary Gland - Anatomy, Physiology, Disorders and Imaging Studies
2. Esophageal
- Physiology and Anatomy
- Clinical Studies
- Manometry
3. Gastric Emptying
- Anatomy and Physiology
- Radionuclide Evaluation
4. GI Miscellaneous
- Blood and Protein Loss
- Enterogastric Reflux
- Gastroesophageal Reflux
- Small Bowel Transit
5. GI Bleeding Studies - Including Radionuclide and Angiography
6. Malabsorption Syndromes, Testing and Breath Tests
7. WBC and Inflammatory Bowel Disorders
Musculoskeletal
1. Anatomy, Embryology, Physiology and Bone Metabolism
2. Radiopharmacy, Methodology, Uptake Mechanisms
3. Bone Radiology (including CT and MRI)
- Benign Disease
- Malignant Disease
4. Primary Bone and Cartilage Tumors
5. Metastatic Bone Disease
6. Osteomyelitis and Septic Arthritis
7. Inflammatory Arthridities
8. Sports Nuclear Medicine
9. Avascular Necrosis, Trauma (including non-union pseudoarthrosis, etc)
10. Miscellaneous
- Paget’s, Hypertrophic disease, Metabolic Bone Diseases
11. Osteoporosis/Osteomalacia and Bone Mineral Density
12. Soft Tissues
-Heterotopic Bone
- Muscle Necrosis
- Tumors
13. Evaluation of Prostheses and Arthrography
14. Therapy - Y90 Joints
- Sr89, Sm153 EDTMP, etc. for Metastatic Disease
Pulmonary
1. Anatomy, Embryology, Physiology
2. Pulmonary Function Studies and Blood Gases
3. Chest Radiology including CT and MRI
4. Ventilation/Perfusion Scanning, Radiopharmacy, Procedures, Techniques
5. Pulmonary Emboli (Diagnosis and Treatment) including Venography
6. Malignancy, Trauma, Congenital Abnormalities
7. Interstitial and Inflammatory/Infectious Diseases
The registrar must reach a total of 3,000 documented diagnostic procedures. The minimum recommended number for each procedure is as follows:
a) |
Central nervous system |
100 (80 % SPET or PET) |
b) |
Bone and joints |
600 |
c) |
Cardiovascular system |
500 (80% SPET or PET) |
d) |
Respiratory system |
300 (50% combined V/Q) |
e) |
Gastrointestinal system |
50 |
f) |
Urinary and genital system |
400 |
g) |
Endocrine system |
400 |
h) |
Hematopoietic and lymphatic system |
50 |
i) |
Neoplastic processes |
550 (80 % SPET, PET or SPET/CT, PET/CT) |
j) |
Inflammatory and degenerative processes |
50 |
@font-face { font-family: "Arial"; }@font-face { font-family: "Courier New"; }@font-face { font-family: "Wingdings"; }@font-face { font-family: "Wingdings"; }@font-face { font-family: "Comic Sans MS"; }p.MsoNormal, li.MsoNormal, div.MsoNormal { margin: 0cm 0cm 0.0001pt; font-size: 12pt; font-family: "Times New Roman"; }h1 { margin: 12pt 0cm 3pt; page-break-after: avoid; font-size: 16pt; font-family: Arial; }h3 { margin: 0cm 0cm 0.0001pt 72pt; page-break-after: avoid; font-size: 12pt; font-family: "Times New Roman"; font-weight: normal; font-style: italic; }h5 { margin: 12pt 0cm 3pt; font-size: 13pt; font-family: "Times New Roman"; font-style: italic; }p.MsoFooter, li.MsoFooter, div.MsoFooter { margin: 0cm 0cm 0.0001pt; text-align: justify; line-height: 15pt; font-size: 10pt; font-family: "Comic Sans MS"; }span.Heading1Char { font-family: Arial; font-weight: bold; }span.Heading3Char { font-style: italic; }span.Heading5Char { font-weight: bold; font-style: italic; }span.FooterChar { font-family: "Comic Sans MS"; }.MsoChpDefault { font-size: 10pt; }div.WordSection1 { page: WordSection1; }ol { margin-bottom: 0cm; }ul { margin-bottom: 0cm; }
Copyright © University of Pretoria 2025. All rights reserved.
Get Social With Us
Download the UP Mobile App